Daffodil Health's AI Gambit to Cut Healthcare's Trillion-Dollar Waste

SAN FRANCISCO, CA – February 17, 2026 – Daffodil Health, a technology firm leveraging artificial intelligence to overhaul health insurance administration, has secured $16.3 million in Series A funding. The investment, led by prominent healthcare technology investor Flare Capital Partners, brings the company’s total capital raised to $20.9 million and signals a significant escalation in the battle against administrative inefficiency in the U.S. healthcare system.

The new capital is earmarked to accelerate the deployment of Daffodil’s AI-powered platform, which aims to help health plans and third-party administrators (TPAs) break their dependency on traditional, high-cost claims processing intermediaries. This move comes as employers and patients alike intensify pressure on insurers to rein in soaring healthcare costs and provide greater transparency.

A New Front in the War on Healthcare Costs

The U.S. healthcare system is grappling with a cost crisis of staggering proportions. With healthcare spending approaching 20% of the national economy, the financial burden is increasingly falling on patients. A staggering 41% of Americans carry medical debt, and nearly half of adults report skipping necessary medical care due to cost. A key, though often overlooked, driver of this crisis is administrative waste, a complex web of processes that consumes over $1 trillion annually.

At the heart of this inefficiency are legacy claims systems and a class of vendors often referred to as “percent-of-savings middlemen.” These firms have historically managed out-of-network claims for health plans, taking a percentage of the money they “save” the plan from a provider’s initial bill. Critics argue this model creates perverse incentives, rewarding opacity and fostering conflict rather than promoting fair, transparent pricing. These legacy systems are often ill-equipped to handle modern, flexible plan designs like reference-based pricing or tiered networks, which are crucial for cost control.

“For too long, health plans have been unable to meaningfully address the healthcare cost crisis because they’ve been forced to pay high fees to middlemen whose incentives often make the problem worse,” said Navin Nagiah, CEO and co-founder of Daffodil Health. “At Daffodil, we believe removing these low-value intermediaries from out-of-network repricing and payment integrity is the first step toward modernizing the archaic practices and systems that continue to drive up costs.”

The AI-Powered Alternative

Daffodil Health is positioning itself as a direct challenger to this old guard. Instead of offering a managed service that operates as a black box, the company provides a transparent, AI-centric Software-as-a-Service (SaaS) platform. This model empowers health plans to bring complex functions like out-of-network repricing and payment integrity analysis in-house, giving them direct control over their pricing logic and claims data without a proportional increase in labor costs.

The platform promises real-time claims support and automated negotiations, using AI to analyze claims and apply pricing rules based on transparent, defensible benchmarks. This stands in stark contrast to the delayed, manual, and often opaque processes of legacy vendors. By shifting from a variable percentage-of-savings fee to a predictable SaaS subscription, Daffodil allows health plans to better forecast their administrative expenses.

The company reports that its approach delivers substantial results. Across its current partners, Daffodil claims to have achieved consistent seven-figure improvements in plan margins. In one notable deployment, a payer partner reportedly saved approximately $4 million in its first year, a figure derived solely from the reduction in fees previously paid to legacy vendors, even before factoring in the downstream savings from more efficient pricing and processing.

Navigating a New Regulatory Landscape

Daffodil’s emergence is timed perfectly with a seismic shift in the regulatory environment. Landmark legislation like the No Surprises Act, which took effect in 2022, has radically altered the landscape for out-of-network billing. The law protects patients from unexpected bills and establishes a federal process for resolving payment disputes between providers and payers. This has placed immense pressure on health plans to justify their payment amounts using solid data.

Furthermore, the Transparency in Coverage Rule mandates that health plans disclose their negotiated rates and out-of-network allowed amounts in publicly accessible, machine-readable files. Together, these regulations have rendered the opaque methods of the past untenable. Health plans now require pricing and payment methodologies that are not just cost-effective, but also transparent, auditable, and capable of withstanding intense regulatory and legal scrutiny.

This is where Daffodil’s emphasis on “defensible benchmarks” becomes critical. By providing an AI-driven tool to establish and apply these benchmarks in real-time, the platform offers health plans a path to compliance and risk mitigation. The ability to generate a clear, data-backed audit trail for every pricing decision is a powerful advantage in an era where every out-of-network claim payment could potentially be challenged.

The Investor Bet on Administrative Disruption

The strong backing from investors like Flare Capital Partners, LRVHealth, and returning investor Maverick Ventures underscores the growing conviction that technology can solve the business of healthcare. These firms are betting that AI is the key to unlocking massive value by streamlining bloated administrative functions.

“Daffodil is redefining how health plans and TPAs modernize plan design, pricing, and claims infrastructure while helping payors capture more margin and deliver more member-centric experiences,” commented Parth Desai, Partner at Flare Capital Partners. “With AI-native automation and auditability built in, Daffodil enables faster, defensible pricing and plan design decisions, at scale, that legacy incumbents and point solutions can’t match.”

This investment is more than just a vote of confidence in a single company; it represents a strategic strike against a trillion-dollar problem. By arming health plans with modern tools, Daffodil Health and its backers are wagering that the industry is finally ready to move beyond its reliance on costly intermediaries. The infusion of $16.3 million gives the company the resources to accelerate this transition, setting the stage for a new competitive dynamic in the management of U.S. healthcare costs.